High Glucose Attenuates Protein S-Nitrosylation in Endothelial Cells
Role of Oxidative Stress
- 1Signal Transduction Laboratory, Division of Human Immunology, Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, Australia;
- 2Signal Transduction Laboratory, Centenary Institute, and Faculty of Medicine, the University of Sydney, Sydney, Australia.
- Address correspondence and reprint requests to Pu Xia, MD, Signal Transduction Laboratory, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia. E-mail: p.xia{at}centenary.org.au.
Abstract
OBJECTIVE Hyperglycemia-induced endothelial dysfunction, via a defect of nitric oxide (NO) bioactivity and overproduction of superoxide, is regarded as one of the most significant events contributing to the vascular lesions associated with diabetes. However, the mechanisms underlying such hyperglycemic injury remain undefined. We hypothesized that alterations in cellular protein S-nitrosylation may contribute to hyperglycemia-induced endothelial dysfunction.
RESEARCH DESIGN AND METHODS We exposed endothelial cells to high glucose in the presence and absence of reactive oxygen species inhibitors and used the biotin switch assay to analyze the alteration in the global pattern of protein S-nitrosylation compared with cells cultured under normal glucose conditions. We identified endogenous S-nitrosylated proteins by mass spectrometry and/or immunoblotting with specific antibodies.
RESULTS High-glucose treatment induced a significant reduction of endogenous S-nitrosylated proteins that include endothelial NO synthase, β-actin, vinculin, diacylglycerol kinase-α, GRP78, extracellular signal–regulated kinase 1, and transcription factor nuclear factor-κB (NF-κB). Interestingly, these changes were completely reversed by inhibition of superoxide production, suggesting a key role for oxidative stress in the regulation of S-nitrosylation under hyperglycemic conditions. In addition, we found that in parallel with the restoration of decreased S-nitrosylation of NF-κB, high glucose–induced NF-κB activation was blocked by the superoxide inhibitors.
CONCLUSIONS The alterations in protein S-nitrosylation may underlie the adverse effect of hyperglycemia on the vasculature, such as endothelial dysfunction and the development of diabetic vascular complications.
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Abbreviations:
- 4-OHCA
- α-cyano-4-hydroxycinnamic acid
- CCCP
- carbonyl cyanide m-chlorophenyl hydrazone
- DPI
- diphenyleneiodonium
- eNOS
- endothelial nitric oxide synthase
- FITC
- fluorescein isothiocyanate
- GSNO
- nitrosylated glutathione
- GSH
- reduced glutathione
- HEN
- HEPES, EDTA, neocuproine
- HUVEC
- human umbilical vein endothelial cell
- IKKβ
- inhibitory κB kinase-β
- mETC
- mitochondrial electron transport chain
- NF-κB
- nuclear factor-κB
- NOS
- nitric oxide synthase
- NOX
- NAD(P)H oxidase
- oxLDL
- oxidized LDL
- ROS
- reactive oxygen species
- TNF-α
- tumor necrosis factor-α
- TTFA
- thenoyltrifluoroacetone.
-
- Received September 13, 2006.
- Accepted August 12, 2007.
- © 2007 American Diabetes Association
